home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Laboratory Inspections – Be Prepared, Be Validated and Avoid Observations - Seminar By ComplianceOnline

 
  July 24, 2012  
     
 
ComplianceOnline, Sheraton San Diego Hotel and Marina 1380 Harbor Island Drive San Diego, CA
2012-08-23


Course Description:

In every laboratory inspection there are always two teams – the auditors and the auditees. Whether you are performing the audit or receiving the audit, there are rules, techniques and tips that will make your job more effective and reduce audit observations. This interactive and exciting seminar will look at various laboratory audits (GLP, cGMP, GCP, EPA) from both perspectives. You learn what auditor s look for, see examples of best practices and also hear war stories of things gone wrong as you get to experience both sides of the process. We will use presentation, discussion, exercises, role playing and workshops so that you experience what it is like to be an auditor and how to receive an audit. 

Course Objectives:

  • Be prepared to receive both internal and external audits.
  • Reduce the anxiety, costs and observations of audits.
  • Know what to say and show, and what Not to say and show.
  • Understand how auditors think and what they are looking for.
  • Write responses, audit observations, corrective actions and remediation plans.
  • Learn the best practices for test method validation, instrument qualification and data system validation to avoid observations (“483s”).
  • Know when to do what to meet audit requirements economically.
  • Have the answers to the auditors' questions.

 

 
 
Organized by: ComplianceOnline
Invited Speakers:

Dr. Richard Poser

President, First Quality Inc

Dr. Richard Poser has been both receiving and conducting audits in drug, laboratory, device, software and manufacturing environments for over 25 years and teaches from personal experience.  He has been Director of Laboratories in both R&D, clinical phase and commercial operations in drugs and medical devices, and has been a consulting quality systems advisor or auditor to dozens of diagnostic, biologics, pharmaceutical and medical device manufacturers including many of the Fortune 500.   Following many inspections he has been retained to design remediation and corrective actions to attain regulatory compliance.

 
Deadline for Abstracts: 2012-08-22
 
Registration:
For Registration:
 
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.